CAS 4790-08-3: 5,6-Dihydroxyindole-2-carboxylic acid

Stability Air Sensitive Applications 5,6-Dihydroxyindole-2-carboxylic Acid is the indole analogue of DOPA. 5,6-Dihydroxyindole-2-carboxylic Acid is a precursor to melanin as well as potential as HIV-1 integrase inhibitors. References Hansson, C.: Acta Derm.-Venereol., 63, 147 (1983); Sechi, M. et al.: Antiviral Chem. Chemother., 15, 67 (2004);

5,6-Dihydroxy-1H-indole-2-carboxylic acid (5,6 DHICA) is a photosensitizing agent with a long detection time. It has been used in the treatment of cervical cancer and skin cancer. 5,6 DHICA is an inhibitor of tyrosinase, which is responsible for the synthesis of melanin. 5,6 DHICA prevents the conversion of dopachrome to eumelanin by binding to the active site of tyrosinase and inhibiting its activity. This makes it an important drug for the treatment of hyperpigmentation disorders such as vitiligo and melasma.

DHICA (5,6-Dihydroxyindole-2-carboxylic acid) is an intermediate in melanin synthesis and a component of eumelanin, as well as acting as a moderate potency agonist of GPR35. In the U2OS cell line, DHICA demonstrates the ability to induce β-arrestin translocation signaling with an EC50 value of 23.2 μM. Additionally, it plays a significant role in promoting and protecting against DNA damage.